article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.

article thumbnail

Informatics helps virtual biotech bring compound to clinical trial

Drug Discovery World

Libra Therapeutics is a San Diego-based biotech focused on developing novel disease-modifying therapeutics, which restore the cellular balance that is disrupted in neurodegenerative diseases. This article is sponsored by Collaborative Drug Discovery. Users can also export data into Excel, so outgoing files can be password protected.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI use in repurposing drugs for Covid-19

Drug Discovery World

We witnessed the unprecedented pace of vaccine development, fuelled by cutting-edge mRNA technology. This is exactly the type of problem that an AI-powered drug discovery engine is designed to address. There was an urgent need for quick and adaptable drug discovery in the context of a complex and poorly understood disease.

Drugs 59
article thumbnail

Re-assessing the risks of drug-induced arrhythmias during drug discovery

Drug Discovery World

Although such electrophysiological systems may be more predictive of potential cardiac safety and efficacy than non-functional binding assays, many apparently attractive new drugs are still being discontinued later in development. Unexpected late-stage failures in drug development are, of course, the costliest.

Drugs 52